The overall objectives of this competing continuation application are to strengthen and expand the existing partnership for cancer research between Meharry Medical College (MMC) and the Vanderbilt Ingram Cancer Center (VICC) to achieve three ends: (1) to increase and stabilize the competitive cancer research capability of MMC;(2) to create stable, long term collaborative relationships between MMC and the VICC in cancer research, research training and career development;(3) to promote, enable and cement a stable, reciprocal, long-term partnership between MMC and VICC based on mutually beneficial research excellence. This partnership is one of very few U54s with a balanced focus on population sciences, basic and clinical research. In this application we seek to expand MMC's competitive cancer research capability by means of one full research project, three pilot projects, and two pre-pilots. All seven projects involve collaborators at VICC, thus strengthening the relationship that VICC and MMC have established during the first funding period. In addition, we seek to establish new core resources for tissue acquisition, biostatistics and community outreach, and to continue a clinical trials core that enables MMC to participate in national oncology trials. We plan also to recruit new faculty investigators in basic science, medical oncology, and epidemiology, and to expand our existing research training program for doctoral students by adding a fellow in medical oncology. All of these activities involve coordinated, well-planned interaction between MMC and VICC and will be monitored by an internal advisory committee composed of members from both schools, and a Program Steering Committee composed of nationally-recognized cancer investigators from other institutions. The proposed project will move the Meharry-Vanderbilt Cancer Partnership toward a fully reciprocal relationship characterized by shared pursuit of excellence and full sharing of each others'strengths.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54CA091408-10
Application #
7849735
Study Section
Special Emphasis Panel (ZCA1-SRRB-Y (O1))
Program Officer
Wali, Anil
Project Start
2001-08-03
Project End
2013-07-31
Budget Start
2010-08-01
Budget End
2013-07-31
Support Year
10
Fiscal Year
2010
Total Cost
$1,949,820
Indirect Cost
Name
Meharry Medical College
Department
Biochemistry
Type
Schools of Medicine
DUNS #
041438185
City
Nashville
State
TN
Country
United States
Zip Code
37208
Wilson, Andrew J; Stubbs, Matthew; Liu, Phillip et al. (2018) The BET inhibitor INCB054329 reduces homologous recombination efficiency and augments PARP inhibitor activity in ovarian cancer. Gynecol Oncol 149:575-584
Banks, Leah D; Amoah, Priscilla; Niaz, Mohammad S et al. (2016) Olive oil prevents benzo(a)pyrene [B(a)P]-induced colon carcinogenesis through altered B(a)P metabolism and decreased oxidative damage in Apc(Min) mouse model. J Nutr Biochem 28:37-50
Pulliam, Stephanie R; Uzhachenko, Roman V; Adunyah, Samuel E et al. (2016) Common gamma chain cytokines in combinatorial immune strategies against cancer. Immunol Lett 169:61-72
Uzhachenko, Roman; Shanker, Anil; Dupont, Geneviève (2016) Computational properties of mitochondria in T cell activation and fate. Open Biol 6:
Wilson, Andrew J; Sarfo-Kantanka, Kofi; Barrack, Toby et al. (2016) Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib. Gynecol Oncol 143:143-151
Xie, Yingqiu; Lu, Wenfu; Liu, Shenji et al. (2016) MMP7 interacts with ARF in nucleus to potentiate tumor microenvironments for prostate cancer progression in vivo. Oncotarget 7:47609-47619
Pulliam, Stephanie R; Pellom Jr, Samuel T; Shanker, Anil et al. (2016) Butyrate regulates the expression of inflammatory and chemotactic cytokines in human acute leukemic cells during apoptosis. Cytokine 84:74-87
Fair, Alecia Malin; Lewis, Toni J; Sanderson, Maureen et al. (2015) Increased vitamin D and calcium intake associated with reduced mammographic breast density among premenopausal women. Nutr Res 35:851-857
Uzhachenko, Roman; Shanker, Anil; Yarbrough, Wendell G et al. (2015) Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity. Oncotarget 6:20754-72
Wilson, Andrew J; Fadare, Oluwole; Beeghly-Fadiel, Alicia et al. (2015) Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer. Oncotarget 6:21353-68

Showing the most recent 10 out of 95 publications